脓毒症相关肺损伤/ARDS的研究进展:聚焦miRNA调控机制与巨噬细胞极化
Research Progress in Sepsis-Associated Lung Injury/ARDS: Focus on miRNA Regulatory Mechanisms and Macrophage Polarization
DOI: 10.12677/acm.2026.1651947, PDF,   
作者: 何宣璋:吉首大学株洲临床学院,湖南 株洲;曾维忠*:株洲市中心医院重症医学科,湖南 株洲
关键词: 脓毒症急性肺损伤ARDSmiRNA巨噬细胞细胞外囊泡外泌体Sepsis Acute Lung Injury ARDS miRNA Macrophages Extracellular Vesicles Exosomes
摘要: 脓毒症是感染诱发的宿主反应失调综合征,病程中极易并发多器官功能障碍。肺脏因其丰富的血流灌注、复杂的免疫细胞构成以及脆弱的肺泡–毛细血管屏障,往往最早受到波及,并可进一步发展为脓毒症相关肺损伤(sepsis-associated lung injury, SALI)乃至急性呼吸窘迫综合征(acute respiratory distress syndrome, ARDS)。近年的研究逐渐认识到,SALI/ARDS并非单纯由“炎症过强”所驱动,而是由炎症放大、免疫抑制、屏障破坏、凝血失衡和代谢重编程相互交织形成的动态过程。巨噬细胞位于这一过程的枢纽位置,既参与病原识别、炎症放大和程序性死亡,也决定凋亡细胞清除、炎症消退与组织修复能否顺利完成。与之相对应,microRNA (miRNA)依靠多靶点、网络式的转录后调控,深度介入巨噬细胞极化可塑性、炎性小体激活、焦亡阈值、免疫代谢重塑以及细胞外囊泡介导的细胞间通讯,因此被认为是解释SALI/ARDS生物学异质性的重要分子线索。本文围绕“miRNA–巨噬细胞轴”系统梳理脓毒症相关肺损伤的研究进展,重点讨论其在炎症扩增、程序性死亡、NETs串扰、细胞外miRNA受体识别和肺内免疫微环境重塑中的作用,并结合近年ARDS亚表型、多组学与外泌体递送研究,分析其在早期识别、风险分层、预后评估和靶向干预中的临床转化前景,以期为后续基础研究设计和临床治疗提供参考。
Abstract: Sepsis is a syndrome of dysregulated host responses triggered by infection and is frequently complicated by multiple organ dysfunction during its course. Because of its abundant blood perfusion, complex immune-cell composition, and fragile alveolar-capillary barrier, the lung is often one of the earliest organs to be involved, and may further progress to sepsis-associated lung injury (SALI) and even acute respiratory distress syndrome (ARDS). Recent studies have increasingly recognized that SALI/ARDS is not driven simply by “excessive inflammation”, but rather represents a dynamic process shaped by the interaction of inflammatory amplification, immunosuppression, barrier disruption, coagulation imbalance, and metabolic reprogramming. Macrophages occupy a pivotal position in this process: they participate in pathogen recognition, inflammatory amplification, and programmed cell death, while also determining whether efferocytosis, resolution of inflammation, and tissue repair can proceed effectively. In parallel, microRNAs (miRNAs), through multitarget and network-based post-transcriptional regulation, deeply participate in macrophage polarization plasticity, inflammasome activation, pyroptotic threshold setting, immunometabolic remodeling, and extracellular vesicle-mediated intercellular communication, and are therefore regarded as important molecular clues for explaining the biological heterogeneity of SALI/ARDS. Focusing on the “miRNA-macrophage axis”, this review systematically summarizes recent progress in sepsis-associated lung injury, with particular attention to its roles in inflammatory amplification, programmed cell death, crosstalk with neutrophil extracellular traps, extracellular miRNA receptor recognition, and remodeling of the pulmonary immune microenvironment. Combined with recent advances in ARDS subphenotypes, multi-omics, and exosome-based delivery, we further analyze the clinical translational prospects of this axis in early identification, risk stratification, prognostic evaluation, and targeted intervention, with the aim of providing references for future basic research design and clinical treatment.
文章引用:何宣璋, 曾维忠. 脓毒症相关肺损伤/ARDS的研究进展:聚焦miRNA调控机制与巨噬细胞极化[J]. 临床医学进展, 2026, 16(5): 1460-1471. https://doi.org/10.12677/acm.2026.1651947

参考文献

[1] Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Journal of the American Medical Association, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
[2] Evans, L., Rhodes, A., Alhazzani, W., et al. (2021) Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine, 49, e1063-e1143.
[3] Matthay, M.A., Arabi, Y., Arroliga, A.C., Bernard, G., Bersten, A.D., Brochard, L.J., et al. (2024) A New Global Definition of Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine, 209, 37-47. [Google Scholar] [CrossRef] [PubMed]
[4] Rudd, K.E., Johnson, S.C., Agesa, K.M., Shackelford, K.A., Tsoi, D., Kievlan, D.R., et al. (2020) Global, Regional, and National Sepsis Incidence and Mortality, 1990-2017: Analysis for the Global Burden of Disease Study. The Lancet, 395, 200-211. [Google Scholar] [CrossRef] [PubMed]
[5] Fleischmann-Struzek, C., Mellhammar, L., Rose, N., Cassini, A., Rudd, K.E., Schlattmann, P., et al. (2020) Incidence and Mortality of Hospital-and ICU-Treated Sepsis: Results from an Updated and Expanded Systematic Review and Meta-Analysis. Intensive Care Medicine, 46, 1552-1562. [Google Scholar] [CrossRef] [PubMed]
[6] Grasselli, G., Calfee, C.S., Camporota, L., Poole, D., Amato, M.B.P., Antonelli, M., et al. (2023) ESICM Guidelines on Acute Respiratory Distress Syndrome: Definition, Phenotyping and Respiratory Support Strategies. Intensive Care Medicine, 49, 727-759. [Google Scholar] [CrossRef] [PubMed]
[7] Alipanah-Lechner, N., Neyton, L., Sinha, P., Leroux, C., Bardillon, K., Carrillo, S.A., et al. (2025) Longitudinal Multiomic Signatures of ARDS and Sepsis Inflammatory Phenotypes Identify Pathways Associated with Mortality. Journal of Clinical Investigation, 136, e196290.
[8] Calfee, C.S., Delucchi, K.L., Sinha, P., Matthay, M.A., Hackett, J., Shankar-Hari, M., et al. (2018) Acute Respiratory Distress Syndrome Subphenotypes and Differential Response to Simvastatin: Secondary Analysis of a Randomised Controlled Trial. The Lancet Respiratory Medicine, 6, 691-698. [Google Scholar] [CrossRef] [PubMed]
[9] Sinha, P., Delucchi, K.L., Thompson, B.T., McAuley, D.F., Matthay, M.A. and Calfee, C.S. (2018) Latent Class Analysis of ARDS Subphenotypes: A Secondary Analysis of the Statins for Acutely Injured Lungs from Sepsis (SAILS) Study. Intensive Care Medicine, 44, 1859-1869. [Google Scholar] [CrossRef] [PubMed]
[10] Delucchi, K., Famous, K.R., Ware, L.B., Parsons, P.E., Thompson, B.T. and Calfee, C.S. (2018) Stability of ARDS Subphenotypes over Time in Two Randomised Controlled Trials. Thorax, 73, 439-445. [Google Scholar] [CrossRef] [PubMed]
[11] Reilly, J.P., Calfee, C.S. and Christie, J.D. (2019) Acute Respiratory Distress Syndrome Phenotypes. Seminars in Respiratory and Critical Care Medicine, 40, 019-030. [Google Scholar] [CrossRef] [PubMed]
[12] Levine, A.R. and Calfee, C.S. (2024) Subphenotypes of Acute Respiratory Distress Syndrome: Advancing towards Precision Medicine. Tuberculosis and Respiratory Diseases, 87, 1-11. [Google Scholar] [CrossRef] [PubMed]
[13] Zampieri, F.G., Bagshaw, S.M. and Cavalcanti, A.B. (2025) Addressing Heterogeneous Treatment Effects in Acute Care Syndromes: Principles and Practical Considerations. Thorax, 80, 765-774. [Google Scholar] [CrossRef] [PubMed]
[14] Matthay, M.A., Arabi, Y.M., Siegel, E.R., Ware, L.B., Bos, L.D.J., Sinha, P., et al. (2020) Phenotypes and Personalized Medicine in the Acute Respiratory Distress Syndrome. Intensive Care Medicine, 46, 2136-2152. [Google Scholar] [CrossRef] [PubMed]
[15] Anesi, G.L., Ramkillawan, A., Invernizzi, J., et al. (2024) Operationalizing the New Global Definition of ARDS: A Retrospective Cohort Study from South Africa. CHEST Critical Care, 2, Article 100103. [Google Scholar] [CrossRef] [PubMed]
[16] Huang, H., Zhu, J., Gu, L., Hu, J., Feng, X., Huang, W., et al. (2022) TLR7 Mediates Acute Respiratory Distress Syndrome in Sepsis by Sensing Extracellular miR-146a. American Journal of Respiratory Cell and Molecular Biology, 67, 375-388. [Google Scholar] [CrossRef] [PubMed]
[17] Zheng, X., Zhang, Y., Lin, S., Li, Y., Hua, Y. and Zhou, K. (2023) Diagnostic Significance of MicroRNAs in Sepsis. PLOS ONE, 18, e0279726. [Google Scholar] [CrossRef] [PubMed]
[18] Shen, X., Zhang, J., Huang, Y., Tong, J., Zhang, L., Zhang, Z., et al. (2020) Accuracy of Circulating MicroRNAs in Diagnosis of Sepsis: A Systematic Review and Meta-Analysis. Journal of Intensive Care, 8, Article No. 84. [Google Scholar] [CrossRef] [PubMed]
[19] van der Velden, S., van Osch, T.L.J., Seghier, A., Bentlage, A.E.H., Mok, J.Y., Geerdes, D.M., et al. (2024) Complement Activation Drives Antibody-Mediated Transfusion-Related Acute Lung Injury via Macrophage Trafficking and Formation of Nets. Blood, 143, 79-91. [Google Scholar] [CrossRef] [PubMed]
[20] Bellani, G., Laffey, J.G., Pham, T., Fan, E., Brochard, L., Esteban, A., et al. (2016) Epidemiology, Patterns of Care, and Mortality for Patients with Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. Journal of the American Medical Association, 315, 788-800. [Google Scholar] [CrossRef] [PubMed]
[21] Smit, M.R., Brower, R.G., Parsons, P.E., Phua, J. and Bos, L.D.J. (2024) The Global Definition of Acute Respiratory Distress Syndrome: Ready for Prime Time? American Journal of Respiratory and Critical Care Medicine, 209, 14-16. [Google Scholar] [CrossRef] [PubMed]
[22] Arora, S., Dev, K., Agarwal, B., Das, P. and Syed, M.A. (2018) Macrophages: Their Role, Activation and Polarization in Pulmonary Diseases. Immunobiology, 223, 383-396. [Google Scholar] [CrossRef] [PubMed]
[23] Malainou, C., Abdin, S.M., Lachmann, N., Matt, U. and Herold, S. (2023) Alveolar Macrophages in Tissue Homeostasis, Inflammation, and Infection: Evolving Concepts of Therapeutic Targeting. Journal of Clinical Investigation, 133, e170501. [Google Scholar] [CrossRef] [PubMed]
[24] Wei, X., Yi, X., Liu, J., et al. (2024) Circ-phkb Promotes Cell Apoptosis and Inflammation in LPS-Induced Alveolar Macrophages via the TLR4/MyD88/NF-kB/CCL2 Axis. Respiratory Research, 25, Article No. 62. [Google Scholar] [CrossRef] [PubMed]
[25] Sun, M., Li, Y., Xu, G., Zhu, J., Lu, R., An, S., et al. (2024) Sirt3-Mediated Opa1 Deacetylation Protects against Sepsis-Induced Acute Lung Injury by Inhibiting Alveolar Macrophage Pro-Inflammatory Polarization. Antioxidants & Redox Signaling, 41, 1014-1030. [Google Scholar] [CrossRef] [PubMed]
[26] Cui, Y., Yang, Y., Tao, W., Peng, W., Luo, D., Zhao, N., et al. (2023) Neutrophil Extracellular Traps Induce Alveolar Macrophage Pyroptosis by Regulating NLRP3 Deubiquitination, Aggravating the Development of Septic Lung Injury. Journal of Inflammation Research, 16, 861-877. [Google Scholar] [CrossRef] [PubMed]
[27] Liang, L., Xu, W., Shen, A., Fu, X., Cen, H., Wang, S., et al. (2023) Inhibition of YAP1 Activity Ameliorates Acute Lung Injury through Promotion of M2 Macrophage Polarization. MedComm, 4, e293. [Google Scholar] [CrossRef] [PubMed]
[28] Mahida, R.Y., Scott, A., Parekh, D., Lugg, S.T., Hardy, R.S., Lavery, G.G., et al. (2021) Acute Respiratory Distress Syndrome Is Associated with Impaired Alveolar Macrophage Efferocytosis. European Respiratory Journal, 58, Article 2100829. [Google Scholar] [CrossRef] [PubMed]
[29] Jiang, Y., Rosborough, B.R., Chen, J., Das, S., Kitsios, G.D., McVerry, B.J., et al. (2020) Single Cell RNA Sequencing Identifies an Early Monocyte Gene Signature in Acute Respiratory Distress Syndrome. JCI Insight, 5, e135678. [Google Scholar] [CrossRef] [PubMed]
[30] Tang, J., Yan, M., Li, M., Hu, Z. and Zhou, K. (2025) From “Metabolic Storm” to “Immune Paralysis”: The Dynamic Evolution of Macrophages and Metabolism Reprogramming in ARDS. Frontiers in Immunology, 16, Article 1738713. [Google Scholar] [CrossRef
[31] Jiang, K., Yang, J., Guo, S., Zhao, G., Wu, H. and Deng, G. (2019) Peripheral Circulating Exosome-Mediated Delivery of miR-155 as a Novel Mechanism for Acute Lung Inflammation. Molecular Therapy, 27, 1758-1771. [Google Scholar] [CrossRef] [PubMed]
[32] Zhao, X., Xie, J., Duan, C., Wang, L., Si, Y., Liu, S., et al. (2024) ADAR1 Protects Pulmonary Macrophages from Sepsis-Induced Pyroptosis and Lung Injury through miR-21/a20 Signaling. International Journal of Biological Sciences, 20, 464-485. [Google Scholar] [CrossRef] [PubMed]
[33] Hawez, A., Taha, D., Algaber, A., Madhi, R., Rahman, M. and Thorlacius, H. (2022) miR-155 Regulates Neutrophil Extracellular Trap Formation and Lung Injury in Abdominal Sepsis. Journal of Leukocyte Biology, 111, 391-400. [Google Scholar] [CrossRef] [PubMed]
[34] Leonard, J. and Sinha, P. (2024) Precision Medicine in Acute Respiratory Distress Syndrome: Progress, Challenges, and the Road Ahead. Clinics in Chest Medicine, 45, 835-848. [Google Scholar] [CrossRef] [PubMed]
[35] Hayase, N. and Doi, K. (2024) How Do We Bridge the Gap between Animal Models of Sepsis and Patients? Kidney360, 5, 637-638. [Google Scholar] [CrossRef] [PubMed]
[36] Ektesabi, A.M., Simone, J., Vaswani, C., Tan, G.W., Wang, Y., Pavelick, J.L., et al. (2024) Pre-Clinical Studies of MicroRNA-Based Therapies for Sepsis: A Scoping Review. Oxygen, 4, 20-36. [Google Scholar] [CrossRef
[37] Chen, F., Wang, N., Liao, J., Jin, M., Qu, F., Wang, C., et al. (2024) Esculetin Rebalances M1/M2 Macrophage Polarization to Treat Sepsis-Induced Acute Lung Injury through Regulating Metabolic Reprogramming. Journal of Cellular and Molecular Medicine, 28, e70178. [Google Scholar] [CrossRef] [PubMed]
[38] Zhang, S., Liu, Y., Zhang, X., Sun, Y. and Lu, Z. (2024) ANKRD22 Aggravates Sepsis-Induced ARDS and Promotes Pulmonary M1 Macrophage Polarization. Journal of Translational Autoimmunity, 8, Article 100228. [Google Scholar] [CrossRef] [PubMed]
[39] Mahida, R.Y., Matsumoto, S. and Matthay, M.A. (2020) Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome. American Journal of Respiratory Cell and Molecular Biology, 63, 15-24. [Google Scholar] [CrossRef] [PubMed]
[40] Quan, C., Wang, M., Chen, H. and Zhang, H. (2021) Extracellular Vesicles in Acute Respiratory Distress Syndrome: Recent Developments from Bench to Bedside. International Immunopharmacology, 100, Article 108118. [Google Scholar] [CrossRef] [PubMed]
[41] Hu, Q., Zhang, S., Yang, Y., Yao, J., Tang, W., Lyon, C.J., et al. (2022) Extracellular Vesicles in the Pathogenesis and Treatment of Acute Lung Injury. Military Medical Research, 9, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[42] Almuntashiri, S., Han, Y., Youngblood, H.A., Chase, A., Zhu, Y., Wang, X., et al. (2022) Identification of Circulating Microvesicle-Encapsulated miR-223 as a Potential Novel Biomarker for ARDS. Physiological Reports, 10, e15494. [Google Scholar] [CrossRef] [PubMed]
[43] Bavuso, M., Miller, N., Sill, J.M., et al. (2024) Extracellular Vesicles in Acute Respiratory Distress Syndrome: Understanding Protective and Harmful Signaling for the Development of New Therapeutics. Histology and Histopathology, 39, 131-144.
[44] dos Santos, C.C., Lopes-Pacheco, M., English, K., Rolandsson Enes, S., Krasnodembskaya, A. and Rocco, P.R.M. (2024) The MSC-EV-MicroRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and Ards. Cells, 13, Article 122. [Google Scholar] [CrossRef] [PubMed]
[45] Xiong, C., Huang, X., Chen, S. and Li, Y. (2023) Role of Extracellular MicroRNAs in Sepsis-Induced Acute Lung Injury. Journal of Immunology Research, 2023, 1-8. [Google Scholar] [CrossRef] [PubMed]
[46] Zhao, C., Luo, Q., Huang, J., Su, S., Zhang, L., Zheng, D., et al. (2023) Extracellular Vesicles Derived from Human Adipose-Derived Mesenchymal Stem Cells Alleviate Sepsis-Induced Acute Lung Injury through a MicroRNA-150-5p-Dependent Mechanism. ACS Biomaterials Science & Engineering, 10, 946-959. [Google Scholar] [CrossRef] [PubMed]
[47] Liu, P., Yang, S., Shao, X., Li, C., Wang, Z., Dai, H., et al. (2024) Mesenchymal Stem Cells-Derived Exosomes Alleviate Acute Lung Injury by Inhibiting Alveolar Macrophage Pyroptosis. Stem Cells Translational Medicine, 13, 371-386. [Google Scholar] [CrossRef] [PubMed]
[48] Deng, W., Zhu, X., Li, H., Hu, P., Qian, K. and Liu, F. (2025) Lung Tissue Extracellular Vesicles-Mediated Delivery of miR-128-3p as a Novel Mechanism of Acute Lung Inflammation. International Journal of Nanomedicine, 20, 4831-4848. [Google Scholar] [CrossRef] [PubMed]
[49] Lin, J., Yang, L., Liu, T., Zhao, H., Liu, Y., Shu, F., et al. (2025) Mannose-Modified Exosomes Loaded with miR-23b-3p Target Alveolar Macrophages to Alleviate Acute Lung Injury in Sepsis. Journal of Controlled Release, 379, 832-847. [Google Scholar] [CrossRef] [PubMed]
[50] Chen, W., Zhang, Y., Chen, J., Dong, S., Wu, X., Wu, Y., et al. (2025) Heme Oxygenase-1 Modulates Macrophage Polarization through Endothelial Exosomal miR-184-3p and Reduces Sepsis-Induce Lung Injury. International Journal of Nanomedicine, 20, 5039-5057. [Google Scholar] [CrossRef] [PubMed]
[51] Lv, J. and Xiong, X. (2024) Extracellular Vesicle MicroRNA: A Promising Biomarker and Therapeutic Target for Respiratory Diseases. International Journal of Molecular Sciences, 25, Article 9147. [Google Scholar] [CrossRef] [PubMed]
[52] Jin, X. and He, M. (2025) Diagnostic Biomarkers and MiRNAs in Prognosis of Acute Respiratory Distress Syndrome. Allergologia et Immunopathologia, 53, 194-200. [Google Scholar] [CrossRef] [PubMed]
[53] do Nascimento, M.F., Ferreira, L.R.P., Vieira Junior, J.M., Deheinzelin, D., Aparecida Santos Nussbaum, A.C., Toshihiro Sakamoto, L.H., et al. (2025) Circulating Extracellular Vesicles as Potential Biomarkers and Mediators of Acute Respiratory Distress Syndrome in Sepsis. Scientific Reports, 15, Article No. 5512. [Google Scholar] [CrossRef] [PubMed]
[54] Wang, Z.F., Yang, Y.M. and Fan, H. (2020) Diagnostic Value of miR-155 for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with Sepsis. Journal of International Medical Research, 48. [Google Scholar] [CrossRef] [PubMed]
[55] Han, Y., Li, Y. and Jiang, Y. (2016) The Prognostic Value of Plasma MicroRNA-155 and MicroRNA-146a Level in Severe Sepsis and Sepsis-Induced Acute Lung Injury Patients. Clinical Laboratory, 62, 2355-2360. [Google Scholar] [CrossRef] [PubMed]
[56] Ohlstrom, D.J., Sul, C., Vohwinkel, C.U., Hernandez-Lagunas, L., Karimpour-Fard, A., Mourani, P.M., et al. (2022) Plasma MicroRNA and Metabolic Changes Associated with Pediatric Acute Respiratory Distress Syndrome: A Prospective Cohort Study. Scientific Reports, 12, Article No. 14560. [Google Scholar] [CrossRef] [PubMed]
[57] Qiu, G., Fan, J., Zheng, G., He, J., Lin, F., Ge, M., et al. (2022) Diagnostic Potential of Plasma Extracellular Vesicle miR-483-3p and Let-7d-3p for Sepsis. Frontiers in Molecular Biosciences, 9, Article 814240. [Google Scholar] [CrossRef] [PubMed]
[58] Lee, L.K., Eghbali, M. and Sapru, A. (2021) A Novel miRNA Biomarker Panel Associated with Mortality in Pediatric Patients with ARDS. Respiratory Research, 22, Article No. 169. [Google Scholar] [CrossRef] [PubMed]
[59] Geng, J., Zheng, Z., Li, L., Ren, Z., Tian, G., Qin, J., et al. (2025) Apigenin Attenuated Sepsis Induced Acute Lung Injury via Polarizing Macrophage Towards M2 by Blocking miR-146a→TLR7 Interaction. International Immunopharmacology, 152, Article 114446. [Google Scholar] [CrossRef] [PubMed]
[60] Petrick, P.L., Mirus, M., Heubner, L., Harb, H., Menk, M. and Spieth, P.M. (2025) Clinical Phenotyping in Acute Respiratory Distress Syndrome: Steps Towards Personalized Medicine. Journal of Clinical Medicine, 14, Article 7204. [Google Scholar] [CrossRef
[61] Parzibut, G., Henket, M., Moermans, C., Struman, I., Louis, E., Malaise, M., et al. (2021) A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome. Frontiers in Molecular Biosciences, 8, Article 640042. [Google Scholar] [CrossRef] [PubMed]
[62] Morrison, T.J., Jackson, M.V., Cunningham, E.K., Kissenpfennig, A., McAuley, D.F., O’Kane, C.M., et al. (2017) Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer. American Journal of Respiratory and Critical Care Medicine, 196, 1275-1286. [Google Scholar] [CrossRef] [PubMed]
[63] Lv, K. and Liang, Q. (2025) Macrophages in Sepsis-Induced Acute Lung Injury: Exosomal Modulation and Therapeutic Potential. Frontiers in Immunology, 15, Article 1518008. [Google Scholar] [CrossRef] [PubMed]